Rituximab in Treating Patients With Peripheral Neuropathy Caused by Monoclonal Gammopathy of Undetermined Significance
type: MedicalStudy
description: A Phase II Trial of Rituximab for Peripheral Neuropathy Associated With Monoclonal Gammopathy of Undetermined Significance (MGUS)
status: TERMINATED
study design: INTERVENTIONAL
phase: PHASE2
start date: 2005-01
end date: 2011-02
license: https://creativecommons.org/publicdomain/zero/1.0/
source: https://clinicaltrials.gov/study/NCT00588822
source organization: US National Library of Medicine
publisher: AI Analytics
sponsor: Mayo Clinic
study subject: Precancerous Condition
keywords: PHASE2
keywords: INTERVENTIONAL
keywords: TERMINATED
keywords: Precancerous Condition

AI Analytics
type: Organization